Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | (FY)Dec 31, 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 34.80%10.35B | 28.62%7.68B | -45.62%5.97B | 188.31%10.97B | 59.65%3.81B | 340.81%2.38B | -106.68%-990M | 76.02%14.82B | 1,495.85%8.42B | -105.88%-603M |
Net profit before non-cash adjustment | -71.66%2.95B | 69.46%10.42B | 157.37%6.15B | 116.63%2.39B | -549.55%-14.36B | -60.79%3.2B | 3,107.01%8.15B | 97.88%-271M | -209.58%-12.75B | 213.35%11.64B |
Total adjustment of non-cash items | 444.34%4.67B | -77.60%857M | -16.08%3.83B | -60.98%4.56B | 5,712.44%11.68B | -92.63%201M | -33.82%2.73B | -75.04%4.12B | 316.31%16.5B | -1,653.77%-7.63B |
-Depreciation and amortization | 19.57%2.95B | 15.96%2.46B | 16.45%2.12B | -25.15%1.82B | 41.60%2.44B | 20.10%1.72B | -6.83%1.43B | -53.35%1.54B | 24.46%3.3B | 10.61%2.65B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | 59.46%472M | -95.78%296M | --7.01B | ---- | -97.06%57M | -79.84%1.94B | 12,376.62%9.61B | --77M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 50.26%-1.25B | -38.08%-2.51B |
-Share of associates | 198.27%1.87B | -954.71%-1.91B | -79.89%223M | 60.03%1.11B | 1,274.58%693M | -111.64%-59M | -15.50%507M | -62.94%600M | 2,316.42%1.62B | 221.82%67M |
-Disposal profit | -96.58%15M | -49.77%439M | 8.30%874M | -3.00%807M | 160.12%832M | -256.38%-1.38B | 362.61%885M | -109.89%-337M | 314.86%3.41B | 213.36%821M |
-Net exchange gains and losses | 57.76%-128M | -67.40%-303M | -257.39%-181M | 105.36%115M | 269.70%56M | -353.85%-33M | 1,200.00%13M | -98.46%1M | 114.71%65M | -198.65%-442M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -101.78%-33M | --1.86B |
-Other non-cash items | -124.39%-40M | -47.77%164M | -23.04%314M | -37.33%408M | 1,579.55%651M | 73.96%-44M | -144.47%-169M | 280.09%380M | 97.92%-211M | -6,851.37%-10.15B |
Changes in working capital | 175.74%2.73B | 10.18%-3.6B | -199.63%-4.01B | -37.98%4.02B | 741.44%6.49B | 91.48%-1.01B | -208.21%-11.87B | 135.05%10.97B | 201.21%4.67B | -176.29%-4.61B |
-Change in receivables | -112.66%-965M | 260.79%7.62B | -328.15%-4.74B | 14.36%2.08B | -57.21%1.82B | 170.80%4.25B | -229.33%-6B | -34.71%4.64B | 372.11%7.1B | -171.60%-2.61B |
-Change in inventory | 125.48%2.69B | -585.98%-10.57B | -158.35%-1.54B | -61.69%2.64B | 216.18%6.89B | 28.38%-5.93B | -213.87%-8.28B | 290.71%7.28B | 46.73%1.86B | 12.60%1.27B |
-Change in prepaid assets | 190.96%322M | -32.58%-354M | -14.10%-267M | -211.96%-234M | 480.56%209M | -82.27%36M | 356.96%203M | -106.63%-79M | 1,879.10%1.19B | 57.05%-67M |
-Change in payables | 232.38%695M | -125.34%-525M | 377.38%2.07B | 68.02%-747M | -400.64%-2.34B | -53.72%777M | 302.29%1.68B | 84.89%-830M | -232.91%-5.49B | -229.51%-1.65B |
-Change in accrued expense | -39.13%126M | -38.39%207M | 918.18%336M | 126.40%33M | -6,150.00%-125M | -100.99%-2M | 213.48%202M | ---178M | --0 | -455.42%-590M |
-Provision for loans, leases and other losses | -125.93%-147M | 323.13%567M | -46.61%134M | 39.44%251M | 700.00%180M | -111.67%-30M | 129.46%257M | --112M | ---- | ---- |
-Changes in other current assets | 100.37%2M | ---546M | --0 | ---- | -45.71%-153M | -256.72%-105M | 91.43%67M | 600.00%35M | 100.52%5M | -8,663.64%-964M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -12.09%-547M | -1.46%-488M | 1.43%-481M | 1.61%-488M | -81.68%-496M | -50.00%-273M | -7.06%-182M | 22.73%-170M | -50.68%-220M | -668.42%-146M |
Interest received (cash flow from operating activities) | -39.48%141M | 92.56%233M | 57.14%121M | -31.86%77M | -28.03%113M | -12.78%157M | 10.43%180M | -22.75%163M | 41.61%211M | 79.52%149M |
Tax refund paid | -3.83%-1.19B | -636.54%-1.15B | -1.30%-156M | 68.18%-154M | 53.46%-484M | -270.11%-1.04B | -17.08%-281M | 12.09%-240M | 58.95%-273M | 66.12%-665M |
Other operating cash inflow (outflow) | 222.22%29M | 104.39%9M | -259.65%-205M | -16.33%-57M | 45.56%-49M | 62.03%-90M | -185.54%-237M | -83M | 0 | -1M |
Operating cash flow | 39.75%8.78B | 19.71%6.28B | -49.32%5.25B | 258.17%10.35B | 153.95%2.89B | 175.36%1.14B | -110.42%-1.51B | 78.06%14.49B | 742.58%8.14B | -115.16%-1.27B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -5.45%-4.78B | -67.03%-4.54B | 41.18%-2.72B | 9.21%-4.62B | 32.72%-5.08B | -94.42%-7.56B | -22.66%-3.89B | -3.77%-3.17B | -61.33%-3.05B | -42.65%-1.89B |
Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --27M | ---- | ---- |
Net business purchase and sale | --27M | --0 | ---- | ---- | --169M | ---- | -99.51%6M | 123,800.00%1.24B | 95.00%-1M | -100.91%-20M |
Net investment product transactions | 30.18%509M | 450.70%391M | 222.73%71M | -94.34%22M | -90.48%389M | 319.43%4.09B | -223.44%-1.86B | -876.27%-576M | 92.84%-59M | 82.33%-824M |
Advance cash and loans provided to other parties | ---- | ---- | ---- | -138.67%-3.98B | -10.46%-1.67B | -113.28%-1.51B | ---708M | --0 | 99.86%-2M | -211.85%-1.45B |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | --922M | ---- | -85.19%36M | -72.94%243M | -46.20%898M | 18,444.44%1.67B | -50.00%9M | -76.32%18M |
Net changes in other investments | 6.25%-420M | 8.38%-448M | -16.71%-489M | 29.70%-419M | 14.12%-596M | -88.08%-694M | -2.79%-369M | -48.35%-359M | 39.35%-242M | -1,187.10%-399M |
Investing cash flow | -1.61%-4.67B | -107.69%-4.59B | 75.42%-2.21B | -33.17%-8.99B | -24.38%-6.75B | 8.32%-5.43B | -405.81%-5.92B | 65.03%-1.17B | 26.64%-3.35B | -8.46%-4.57B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -169.99%-2.41B | 336.08%3.44B | -275.03%-1.46B | -77.70%833M | -34.79%3.74B | 311.76%5.73B | -6.58%-2.71B | 10.57%-2.54B | -190.15%-2.84B | 369.06%3.15B |
Net common stock issuance | 66.67%-1B | ---3B | --0 | ---- | ---- | ---- | ---15M | --0 | --0 | 25.00%-3M |
Cash dividends paid | 43.14%-1.67B | -122.33%-2.94B | ---1.32B | ---- | 81.86%-292M | -9.97%-1.61B | -100.00%-1.46B | 0.00%-732M | -33.09%-732M | 0.00%-550M |
Cash dividends for minorities | 86.11%-5M | ---36M | --0 | --0 | 95.83%-1M | -500.00%-24M | -300.00%-4M | 66.67%-1M | -50.00%-3M | -100.00%-2M |
Net other fund-raising expenses | -6.04%-158M | -5.67%-149M | -6.82%-141M | 7.04%-132M | -105.80%-142M | -76.92%-69M | -200.00%-39M | 58.06%-13M | -24.00%-31M | -92.31%-25M |
Financing cash flow | -95.60%-5.24B | 8.22%-2.68B | -516.55%-2.92B | -78.76%701M | -18.01%3.3B | 195.22%4.03B | -28.71%-4.23B | 8.88%-3.28B | -240.34%-3.6B | 247.76%2.57B |
Net cash flow | ||||||||||
Beginning cash position | -8.89%8.9B | 1.84%9.76B | 26.43%9.59B | -8.11%7.58B | -4.49%8.25B | -57.86%8.64B | 95.27%20.5B | 12.78%10.5B | 9.48%9.31B | 43.97%8.5B |
Current changes in cash | -14.11%-1.13B | -962.61%-992M | -94.41%115M | 464.89%2.06B | -111.24%-564M | 97.71%-267M | -216.25%-11.66B | 748.56%10.03B | 136.22%1.18B | -235.73%-3.26B |
Effect of exchange rate changes | -29.03%88M | 100.00%124M | 212.73%62M | 47.62%-55M | 11.76%-105M | 40.50%-119M | -614.29%-200M | -450.00%-28M | -91.30%8M | -52.08%92M |
Cash adjustments other than cash changes | ---- | ---- | -200.00%-1M | --1M | ---- | -100.00%-2M | ---1M | ---- | ---- | 397,600.00%3.98B |
End cash Position | -11.74%7.85B | -8.89%8.9B | 1.84%9.76B | 26.43%9.59B | -8.11%7.58B | -4.49%8.25B | -57.86%8.64B | 95.27%20.5B | 12.78%10.5B | 9.48%9.31B |
Free cash flow | 129.42%3.99B | -31.29%1.74B | -55.80%2.53B | 360.71%5.72B | 71.60%-2.19B | -42.18%-7.73B | -148.24%-5.43B | 121.93%11.27B | 260.13%5.08B | -145.16%-3.17B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |